Bluejay Diagnostics, Inc.: INTRACOASTAL CAPITAL, LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Intracoastal Capital, LLC amended its Schedule 13G filing on Bluejay Diagnostics, Inc., updating its beneficial ownership stake with the SEC under accession number 0001213900-26-118157. The amendment signals a change in the investor's position in the diagnostics company, though the filing did not disclose the specific size or direction of the stake. Schedule 13G amendments are typically watched for signs of shifting institutional interest in small-cap issuers. Investors will look to the updated filing for details on Intracoastal's holdings and any change in its passive-investor status.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Bluejay Diagnostics, Inc., Intracoastal Capital, LLC